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Abstract
Background: Lipids are a class of molecules that play an important role in cellular structure and metabolism in all
cell types. In the last few decades, it has been reported that long-chain fatty acids (FAs) are involved in several
biological functions from transcriptional regulation to physiological processes. Several fatty acids have been both
positively and negatively implicated in different biological processes in skeletal muscle and other tissues. To gain
insight into biological processes associated with fatty acid content in skeletal muscle, the aim of the present study
was to identify differentially expressed genes (DEGs) and functional pathways related to gene expression regulation
associated with FA content in cattle.
Results: Skeletal muscle transcriptome analysis of 164 Nellore steers revealed no differentially expressed genes
(DEGs, FDR 10%) for samples with extreme values for linoleic acid (LA) or stearic acid (SA), and only a few DEGs for
eicosapentaenoic acid (EPA, 5 DEGs), docosahexaenoic acid (DHA, 4 DEGs) and palmitic acid (PA, 123 DEGs), while
large numbers of DEGs were associated with oleic acid (OA, 1134 DEGs) and conjugated linoleic acid cis9 trans11
(CLA-c9t11, 872 DEGs). Functional annotation and functional enrichment from OA DEGs identified important genes,
canonical pathways and upstream regulators such as SCD, PLIN5, UCP3, CPT1, CPT1B, oxidative phosphorylation
mitochondrial dysfunction, PPARGC1A, and FOXO1. Two important genes associated with lipid metabolism, gene
expression and cancer were identified as DEGs between animals with high and low CLA-c9t11, specifically,
epidermal growth factor receptor (EGFR) and RNPS.
Conclusion: Only two out of seven classes of molecules of FA studied were associated with large changes in the
expression profile of skeletal muscle. OA and CLA-c9t11 content had significant effects on the expression level of
genes related to important biological processes associated with oxidative phosphorylation, and cell growth, survival,
and migration. These results contribute to our understanding of how some FAs modulate metabolism and may
have protective health function.
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Background
Lipids are a class of molecules present in all cell types.
They contribute to cellular structure, energy storage and
several biological functions from transcriptional regula-
tion to physiological processes [1]. Over the last couple
decades, it has been reported that consumption of fatty
acids is associated with fat deposition and may have
metabolic effects, such as altered blood lipid and lipo-
protein content [2]. However, there are still contrasting
opinions about the role of dietary fatty acids on human
health, which can be observed in previous reviews and
meta-analysis studies conducted in the last years [3, 4].
Lipid composition in beef has become an important
discussion point. Although meat is a significant source
of fat in the human diet, it contains high saturated fat
content that is associated with some diseases such as
obesity, cancer and coronary heart disease [5, 6]. On the
other hand, meat has high nutritional value and is an
important source of unsaturated fatty acids such as oleic
acid (OA) and conjugated linoleic acid (CLA), which
have beneficial effects on human health [7]. Thus, there
is a need to improve the nutritional value of meat and
better understand the biological and molecular processes
associated with fatty acid composition in skeletal
muscle.
Previous studies have shown that OA as well as other
fatty acids such as linoleic acid (LA), docosahexaenoic
acid (DHA), eicosapentaenoic acid (EPA) and CLA can
regulate gene transcription in tissues such as muscle, liver,
adipose, monocytes and blood mononuclear cells [8, 9].
Activation of nuclear receptors such as peroxisome
proliferator-activated receptors (PPARs) and coactivators
of the sterol response element binding protein (SREBP)
can mediate this regulation. Both PPARs and SREBPs play
a role in preadipocyte differentiation, lipid homeostasis
and peroxisomal beta-oxidation regulation by controlling
the transcription of acyl-CoA oxidase and other enzymes
involved in adipocyte development [10–12]. While ele-
vated intracellular levels of stearic (SA) and palmitic (PA)
acids were associated with apoptotic death [13] and in-
flammatory process [14]. However, the effective involve-
ment of these fatty acids in molecular and physiological
processes in skeletal muscle remains unclear.
The present investigation was undertaken to identify
differentially expressed genes (DEGs) and functional
pathways associated with seven FA content in beef cattle.
Our hypothesis was that variation in FA content could
be associated with difference in gene expression in skel-
etal muscle. Our study revealed that up regulation of
stearoyl-CoA desaturase (SCD) is associated with depos-
ition of unsaturated FA and that increased levels of OA
and CLA are associated with expression of genes that
have protective function associated with important hu-
man diseases.
Results
Phenotypes and sequencing data
Seven different FAs, important to beef quality and human
health, were used in this transcriptome study, including:
oleic acid (OA, C18:1 cis9), palmitic acid (PA, 16:0), ste-
aric acid (SA, C18:0), linoleic acid (LA, C18:2 cis9,12),
conjugated linoleic acid cis9 trans11 (CLA-c9t11, C18:2
cis9 trans11), eicosapentaenoic acid (EPA, C22:5) and doc-
osahexaenoic acid (DHA, C22:6). The skeletal muscle
samples analyzed were chosen based on their extreme
values for each FA studied (Additional file 1). When
ranked by fatty acids content in skeletal muscle, the statis-
tical test of means performed between the high (H) and
low (L) groups according to FA had significant differences
(p-value < 0.05) for OA, PA, SA, CLA-c9t11, LA, EPA and
DHA, but no difference in IMF content or backfat thick-
ness (Additional file 2). However, animals with extreme
phenotypes for OA, PA, SA, CLA-c9t11, LA, EPA and
DHA also had significant differences for other FAs. For
example, animals with high levels of OA had significantly
(p < 0.05) lower levels for SA and PA, but high levels for
CLA-c9t11. While extreme animals for CLA-c9t11 had
significant low levels for SA and PA, but high levels for
OA and DHA. The correlation between any two FAs
tended to be low (<0.2). However, there were some FAs
that high negative correlations, e.g. OA and PA (-0.63)
and OA and SA (-0.62) or high positive correlations, e.g.
EPA and LA (0.66) and EPA and DHA (0.74) (Table 1).
The average number of mapped read pairs per sample
before and after filtering were 14.47 million and 11.5
million respectively (see Additional file 3), which means
that on average 75.85% of total read pairs were mapped
to the Bos taurus UMD3.1 reference genome assembly.
After filtering for transcript expression level, a total of
17,137; 17,070; 17,053; 17,052; 17,038; 16,989 and 17,100
annotated genes were used for differential expression
Table 1 Phenotypic correlation between the groups of extreme
values of fatty acids content in skeletal muscle
Fatty acids PAa SAb OAc LAd CLA-c9t11e EPAf DHAg
PA 1 0.16 −0.63 −0.02 −0.15 −0.15 −0.15
SA 0.16 1 −0.62 0.02 −0.31 −0.02 0.05
OA −0.63 −0.62 1 0.06 0.51 0.06 0.08
LA −0.02 0.02 0.06 1 0.05 0.66 0.53
CLA-c9t11 −0.15 −0.31 0.51 0.05 1 0.07 0.17
EPA −0.15 −0.02 0.06 0.66 0.07 1 0.74
DHA −0.15 0.05 0.08 0.53 0.17 0.74 1
aPalmitic acid
bStearic acid
cOleic acid
dLinoleic acid
eConjugated linoleic acid cis9, trans 11
fEicosapentaenoic acid
gDocosahexaenoic acid
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analysis for OA, PA, SA, CLA-c9t11, EPA, DHA and LA
content, respectively.
Differential expression analysis
Differential gene expression analysis was performed for
each FA by camparing gene expression level between the
H and L FA content groups. No DEGs were identified
for LA and SA (see Additional files 4 and 5), while 5, 4
and 123 DEGs were identified for EPA, DHA and PA,
respectively (see Additional files 6, 7 and 8). In contrast,
1134 and 872 DEGs for OA and CLA-c9t11, respect-
ively, were identified between H and L groups (for more
details see Additional file 9 and 10). A Volcano plot of
log2 fold-change (x-axis) versus − log10 FDR-corrected
p-value (y-axis) for OA is shown in Fig. 1. The volcano
plot of other FAs are shown in Additional file 11. Of the
1134 DEGs for OA, 870 genes were up-regulated and
264 were down-regulated and of the 872 DEGs for CLA-
c9t11, 536 genes were up-regulated and 336 were down-
regulated in the L group relative to the H group. The ex-
pression level, fold change, adjusted p-value and annota-
tion of all DEGs for OA and CLA-c9t11 are shown in
more detail in Additional files 9 and 10.
Functional enrichment analysis for oleic acid content
In this study, two different tools of pathway analysis were
performed: DAVID and Ingenuity Pathway Analysis®
(IPA®). According to DAVID enrichment analysis, several
ontology terms were significantly enriched (p-value
adjusted for multiple testing by Benjamin-Hochberg [15],
BH-adj-pvalue) for the differentially expressed gene lists
(see Additional file 12). Cellular component GO terms
related to mitochondrial envelope (BH-adj-pvalue = 2.6e-
15), mitochondrial membrane (BH-adj-pvalue = 1.0e-14),
respiratory chain (BH-adj-pvalue = 6.6e-12), mitochondrial
matrix (BH-adj-pvalue = 6.0e-08) and intracellular organ-
elle lumen (BH-adj-pvalue = 5.8e-06) were associated with
DEGs for OA content. In addition, six KEGG pathways
(BH-adj-p-value < 0.10) that were associated with oxida-
tive phosphorylation (BH-adj-pvalue = 5.8e-10), ribosome
(BH-adj-pvalue = 1.6e-02) and proteasome (BH-adj-pva-
lue = 2.9e-02) were also identified. These pathways are in-
volved with oxidative phosphorylation and oxidative stress
diseases such as Huntington (BH-adj-pvalue = 3.0E-10),
Parkinson (BH-adj-pvalue = 1.5e-08) and Alzheimer (BH-
adj-pvalue = 1.2E-07) (Table 2).
The IPA® software (IPA®, QIAGEN Redwood City,
www.qiagen.com/ingenuity) was also performed for
functional enrichment using the Global Functional
Analysis (GFA) and Global Canonical Pathways (GCP)
analysis from the DEGs list for OA content (1134 genes).
Global Canonical Pathways analysis estimates the likeli-
hood that the association between a set of DEGs in a
pathway is due to random chance using a right-tailed
Fig. 1 Volcano plot of log2fold-change (x-axis) versus − log10FDR-corrected p-value in RNA-Seq data for oleic acid content
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Fishers Exact Test. Significance was set at BH-adj-pvalue ≤
0.05, which indicated a non-random association. Several ca-
nonical pathways (BH-adj-pvalue ≤ 0.05, which indicated a
non-random association) were identified by GCP analysis,
including oxidative phosphorylation (BH-adj-pvalue = 7.94e-
17), mitochondrial dysfunction (BH-adj-pvalue = 3.98e-16),
insulin receptor signaling (BH-adj-pvalue = 0.02), LPS-stim-
ulated MAPK signaling (BH-adj-pvalue = 0.035), role of
NFAT in cardiac hypertrophy (BH-adj-pvalue = 0.035) and
Huntington’s disease signaling (BH-adj-pvalue = 0.04) (see
Additional file 13).
Twenty-five networks were enriched as a function of
OA content as identified by IPA®GFA analyses (see
Additional file 14). One in particular, shown in Fig. 2,
was associated with lipid metabolism and energy pro-
duction. This network contained molecules and genes
such as cholesterol (LDL-cholesterol), very-low-density
lipoprotein (VLDL-cholesterol), perilipin 5 (PLIN5), SCD,
low-density lipoprotein carnitine palmitoyltransferase I
(CPT1) and carnitine palmitoyltransferase I (CPT1B), re-
spectively (Fig. 2). Among these only SCD was up-
regulated in the H group as shown in red in Fig. 2.
To further explore the observed changes in gene expres-
sion, IPA® upstream regulator analyses were performed to
identify the cascade of upstream transcriptional regulators
that could be involved in the gene expression changes in
skeletal muscle due to OA content. The IPA® program es-
timated the effects between transcriptional regulators and
their target genes based on prior knowledge stored in the
Ingenuity® Knowledge Base. Upstream regulators were
identified from the list of DEGs for OA content (see
Additional file 15), which were connected via mechanistic
networks detected by IPA®. Peroxisome proliferator-
activated receptor gamma, coactivator 1 alpha (PPARGC1A)
was among the top predicted upstream regulators.
PPARGC1A and ten other transcription factors (TFs) such
as forkhead box O3 (FOXO3), peroxisome proliferator-
activated receptor gamma, coactivator 1 beta (PPARGC1B),
estrogen-related receptor gamma (ESRRG), sterol regulatory
element binding transcription factor 1 (SREBF1), tumor pro-
tein p53 (TP53), forkhead box O1 (FOXO1), V-Myc avian
myelocytomatosis viral oncogene homolog (MYC) and myo-
genic differentiation 1 (MYOD1) were predicted to be inhib-
ited (blue shapes in Fig. 3), whereas the transcription factors
forkhead Box O4 (FOXO4) and sterol regulatory element
binding transcription factor 2 (SREBF2) were predicted to
be activated (orange shapes in Fig. 3).
The functional enrichment analysis using the IPA® pro-
gram identified several statically significantly enriched bio-
logical functions (BH-adj-p-value ≤ 0.05) from the OA
DEGs list (see Additional file 16), e.g. processing of RNA
(BH-adj-pvalue = 2.28e-07, mitochondrial disorder (BH-adj-
pvalue = 3.46e-07), transcription of RNA (BH-adj-pvalue =
1.70e-06), expression of RNA (BH-adj-pvalue = 3.30e-06),
transcription of DNA (BH-adj-pvalue = 2.51e-05), expres-
sion of mRNA (BH-adj-pvalue = 4.96e-05), catabolism of
fatty acid (BH-adj-pvalue = 1.86e-03), beta-oxidation of pal-
mitic acid (BH-adj-pvalue = 3.20e-03), depletion of triacyl-
glycerol (BH-adj-pvalue = 9.34e-04 and oxidation of long
chain fatty acid (BH-adj-pvalue = 2.86e-02). The indirect in-
hibitory interaction between SCD and β-oxidation and the
depletion of triacylglycerol, which was associated with lipid
metabolism and energy production are shown in Fig. 4. In
the network shown in Fig. 2 it is also possible to observe the
indirect interaction between SCD, LDL-cholesterol, VLDL-
cholesterol, CPT1, CPT1B, PLIN5 and UCP3.
Functional enrichment analysis for conjugated linoleic
acid cis9 trans11 content
The enrichment analysis performed by DAVID soft-
ware using the list of DEGs for CLA-c9t11 content
identified one KEGG pathway, which was related to
ribosome function (BH-adj-pvalue = 1.2e-02). Among
the molecular functions identified by DAVID associ-
ated (BH-adj-pvalue < 0.05) with the CLA-c9t11 DE
genes identified between the groups with extreme
values of CLA-c9t11 were nucleotide binding (BH-adj-
pvalue = 1.7e-03), ATP binding (BH-adj-pvalue = 2.2e-
02) and structural constituent of ribosome (BH-adj-
pvalue = 2.4e-02) (see Additional file 17).
The top five canonical pathways identified for CLA-
c9t11 content by GFA and GCP analysis using IPA®
Table 2 Pathways identified from differentially expressed genes list between high and low oleic acid content
Category Term Counta %b P-Value BH-adjc
KEGG_PATHWAY Oxidative phosphorylation 33 3.0 3.7e-12 5.8e-10
KEGG_PATHWAY Huntington’s disease 38 3.5 3.9e-12 3.0e-10
KEGG_PATHWAY Parkinson’s disease 30 2.8 2.9e-10 1.5e-8
KEGG_PATHWAY Alzheimer’s disease 32 3.0 3.2e-9 1.2e-7
KEGG_PATHWAY Ribosome 15 1.4 5.0e-4 1.6e-2
KEGG_PATHWAY Proteasome 10 0.9 1.1e-3 2.9e-2
aNumber of differentially expressed genes involved in the term
bPercentage of differentially expressed genes involved in the term
cP-value adjusted for multiple tests by Benjamin and Hochberg (1995)
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program were protein ubiquitination (nominal pvalue =
4.11e-07), interferon signaling (nominal pvalue = 2.9e-
05), hypoxia signaling in the cardiovascular system
(nominal pvalue = 8.8e-05), angiopoietin signaling (nom-
inal pvalue = 1.01e-04) and mTOR signaling (nominal
pvalue = 1.19e-04) (see Additional file 18).
The top five upstream regulators identified from the
list of DEGs for CLA-c9t11, associated network
functions and toxicology list (list of molecules/genes that
are relevant to causality of the phenotype of interest,
which can help to identify potential therapeutic or tox-
icity targets) for CLA-c9t11 content are shown in
Additional file 18. Among the top upstream regulators
were: interferon, lambda 1 (IFLN1), tumor necrosis fac-
tor (TNF), retinoic acid, signal transducer and activator
of transcription 2 (STAT2), and interferon regulatory
Fig. 2 A gene network associated with lipid metabolism and energy production is impacted by OA content. Genes presented in red are up-regulated in the
high oleic acid content (H) group. Genes presented in green are down-regulated in the H group. The intensity of the colors is related to the estimated of fold
change. Molecules in white are not in the DE list, but were incorporated into the network through relationships with other molecules
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factor 7 (IRF7), which were predicted as activated in this
study (see Additional file 19). However other important
cytokines and transcription regulators were identified as
activated/inhibited such as IFNK (interferon kappa), CCL5
(chemokine (C-C motif) ligand 5) and, PRL (prolactin),
TRIM24 (tripartite motif containing 24), NFKB1A (Nu-
clear factor NF-kappa-B 1A), SREBF1, FOXO1, TP53 and
MYC, respectively (see complete list in Additional file 19).
Figure 5 shows the FOXO1 network, which has been asso-
ciated with the metabolic disorder dyslipidemia.
The top five associated network functions detected
from the list of CLA-c9t11 DEGs between the groups
with extreme values of CLA-c9t11 were related to RNA
damage, repair and post-transcriptional modification; de-
velopmental disorder; metabolic disorder; lipid metabol-
ism, molecular transport, RNA trafficking and; cell death
Fig. 3 The mechanistic network of the upstream regulators and their relationship predicted by IPA®. The molecules shown in blue are predicted
to be inhibited, while the molecules shown in orange are predicted to be activated as a result of OA content. Color intensity represents the level
of inhibition or activation. The lines and arrows in blue represent a direct interaction and activation, respectively. The interrupted lines in yellow
represents direct inhibition. The gray lines represent the interactions that OA content did not affect, but have been reported in the literature
Fig. 4 Biological functions that include stearoyl-CoA desaturase such as (a) beta-oxidation of palmitic acid and (b) AGPAT6 depletion of triacyl-
glycerol. Genes shown in red are up-regulated in the high oleic acid content group, while genes shown in green are down-regulated
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and survival (see Additional file 18). Figure 6 illustrates
the network associated with lipid and nucleic acid me-
tabolism and small molecule biochemistry, which pre-
sents epidermal growth factor receptor (EGFR) as a
central gene and which was down-regulated in animals
with high CLA-c9t11 content (colored in green). Figure 7
shows a network associated with molecular transport,
RNA trafficking, RNA post-transcriptional modification
that contained ribonucleoproteins (RNPS), which were
up-regulated in animals with high CLA-c9t11 content.
The top five Toxicology terms were associated with
cardiac necrosis/cell death (nominal p-value = 1.18e-06),
cardiac hypertrophy (nominal p-value = 2.4e-04), hypoxia-
inducible factor signaling (nominal p-value = 3.2e-03), in-
creases liver steatosis (nominal p-value = 3.3e-03) and,
PPARA/RXRA activation (nominal p-value = 5.3e-03) (see
Additional file 18).
Validation of differentially expressed genes
The quantitative real-time polymerase chain reaction
(qRT-PCR) results and the relative quantification of
DEGs selected to validate the present RNA-Seq study
are shown in Additional file 20. Nine genes differently
expressed between high and low OA groups were tested
by qPCR and seven genes (78%) confirmed the RNAseq
data (p < 0.1), one gene confirmed but not at a signifi-
cant level and one gene disagreed with RNAseq data
(Additional file 21).
Discussion
Skeletal muscle is important for energy homeostasis, as
it is a site of energy storage and insulin-stimulated
glucose. Metabolic diseases such as obesity and coronary
disorders could be a consequence of insulin resistance,
i.e. the inability of insulin to drive glucose into the skel-
etal muscle and other tissues as liver, which can be
caused by excessive body fat deposition [16]. Fatty acids
in skeletal muscle play an important role in the struc-
tural and functional processes that influence the fluidity
and stability of membrane structures, which impacts
membrane functions such as transport, cell signaling, re-
sponses to oxidative damage and apoptosis. Studies have
reported that the fatty acid profile of skeletal muscle
phospholipids and triacylglycerides can be influenced by
the fatty acid composition of human and animal diets
[17, 18]. Several saturated and unsaturated fatty acids
have been implicated, both positively and negatively, in
different biological processes in skeletal muscle and
other tissues such as liver and cardiac tissue [1, 19, 20].
In contrast, meta-analysis studies reported no evidence
that a human diet, which was rich in monounsaturated
fatty acids (MUFA) and polyunsaturated fatty acids
(PUFA) and depleted for saturated fatty acid (SFA), had
beneficial effects on coronary heart disease [3, 4].
In this study, all animals were of the same breed, sex,
similar age and fed the same diet. However, different
levels of FA content were observed in skeletal muscle.
This maybe due to genetic variation among the animals
[21] given that the environmental variables were similar
across all animals. Transcriptomic analyses (validated by
q RT-PCR [see Additional file 20]) indicated that many
genes were differentially expressed (FDR 10%) between
animals with high and low OA and CLA-c9t11 content.
While, only a few genes were differentially expressed
Fig. 5 The network of the upstream regulator FOXO1 by IPA®. Genes presented in red are up-regulated in the high oleic acid content (H) group. Genes
presented in green are down-regulated in the H group. The intensity of the colors is related to the estimated of the fold change. The interrupted lines in
orange represents direct inhibition. The blue represents direct activation. The gray lines represent the no interactions have been reported in the literature
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among the extreme groups for PA, SA, EPA and DHA
and none for LA and SA. Additionally, previous studies
reported only a few genes were affected by different
levels of intramuscular fat content [22] and tenderness
[23] in this same population.
Because the samples used for OA and CLA-c9t11 ana-
lysis also differed significantly for other FAs (see
Additional file 2), we cannot be certain that the observed
DE genes for OA and CLA-c9t11 are associated solely
with these FAs. Despite the use of some samples in the
analysis of several FA extremes, the lists of differentially
expressed genes, and identified pathways were very dif-
ferent. This may not be surprising given the generally
low correlation between FAs (Table 1). Thus it is very
likely that utilization of only a couple samples in several
analyses does not have an negative impact on other
analyses. Finally, these findings indicate the biological
importance of OA and CLA-c9t11 for skeletal muscle
physiology. However, a word of caution is necessary be-
cause, a direct relation between gene expression level
and protein abundance was not establish [24]. These
fatty acids may play an important role in transcription
regulation and consequently in energy homeostasis and
metabolic diseases such as obesity and diabetes as also
presented by Ntambi [25].
The most abundant MUFA found in skeletal muscle
fat is oleic acid (OA, C18:1 cis9) [26]. It is present in
membrane phospholipids, triglycerides and cholesterol
esters. Human OA consumption has been associated
with low levels of low-density lipoprotein (LDL) and also
with the potential increase of high-density lipoprotein
(HDL) levels in the blood. Furthermore, OA is converted
to oleoylethanolamide (OEA), a small molecule in the
intestine, which is involved in appetite control [27]. Pre-
vious studies have reported an important contribution of
OA intake to general human health, which could lead to
a decrease in cholesterol levels, atherosclerosis risk and
diabetes occurrence. Further, OA has protective effects
against viral infection and cancer development [28–30].
Beef has a high unsaturated fatty acid profile, primarily
OA [28]. It is considered an important source of OA in
human nutrition, and health [31–33]. Another important
aspect of the OA content in beef is its relationship to
meat quality traits such as tenderness, flavor and shelf-
Fig. 6 Network associated with lipid metabolism, nucleic-acid metabolism and small molecule biochemistry impacted by CLA-c9t11 content.
Genes presented in red are up-regulated in the high CLA-c9t11 content (H) group. Genes presented in green are down-regulated in the H group.
The intensity of the colors is related to estimate of the fold change. Molecules in white are not in the DE list, but were incorporated into the
network through relationships with other molecules
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life [30]. Thus, it is appealing to improve our knowledge
about biological processes associated with OA content
in skeletal muscle, which could both help to improve the
nutritional value and quality of beef.
In mammals, the biosynthesis of the OA is dependent
on the activity of stearoyl-CoA desaturase (SCD). This
soluble enzyme catalyzes the introduction of a cis-double
bond at the 9th carbon position of stearic acid (18:0), to
form the MUFA, oleic acid (18:1) [30]. SCD is also re-
quired for the synthesis of highly unsaturated essential
fatty acids or PUFAs such as eicosopentaenoic (EPA,
C22:5 n-3) and docosahexaenoic acids (DHA, C22:6 n-
6); synthesized from a-linolenic acid (LA, C18:2 cis9,-
cis12), and arachidonic acid (synthesized from linoleic
acid), which are dependent on the presence of oleic acid
[1]. In ruminants, such as beef cattle, the concentration
of OA in adipose tissue depends more on the concentra-
tion of stearic acid hydrogenated by ruminal microor-
ganisms than from stearic acid desaturation by SCD in
the tissues [10].
EPA and DHA are omega-3 (n-3) long-chain PUFA,
which are dietary fats associated with health benefits.
They are present in cell membranes and play a role in
anti-inflammatory processes and in the viscosity of cell
membranes [34]. EPA and DHA are also precursors of
several metabolites that are potent lipid mediators, con-
sidered by many investigators to be beneficial in the pre-
vention or treatment of several diseases such as
cardiovascular, obesity and Alzheimer [35–37]. However,
in this study both EPA and DHA did not appear to have
much of an effect on skeletal muscle gene expression,
which may mean that they do not have a biological effect
on skeletal muscle. It is interesting to speculate that
DEG analyses of other tissues such as liver and adipose
may be able to identify tissues responsive to these fatty
acids. In contrast, Conjugated linoleic acid cis9, trans11
has a large effect on gene expression. This FA is associ-
ated with human health, specifically related with diseases
such as cancer, immune and inflammatory responses
and obesity [38, 39] and is naturally present in food
Fig. 7 Network associated with molecular transport, RNA trafficking and RNA post-transcriptional modification impacted by CLA-c9t11 content.
Genes presented in red are up-regulated in the high CLA-c9t11 content (H) group. Genes presented in green are down-regulated in the H group. The
intensity of the colors is related to estimate of the fold change. Molecules in white are not in the DE list, but were incorporated into the network
through relationships with other molecules
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sources such as fats in milk and meat of ruminant ani-
mals [39]. This may indicate that skeletal muscle is a pri-
mary target of Conjugated linoleic acid cis9, trans11.
The enriched transcript clusters identified by DAVID
based on biological process GO terms (see Additional
files 16 and 18) from the list of DEGs were associated
with electron transport chain, mRNA translation and
generation of precursor metabolites and energy. FAs like
OA and CLA-c9t11 are involved in both extracellular
and intracellular activities, which are in a partially disso-
ciated state at physiological pH with part of the mole-
cules diffused into the cytosol and other part integrating
the membrane structure. These FAs impact several mo-
lecular functions in the cell such as: (1) ion transport
across membranes; (2) activate intracellular enzymes; (3)
modulation of Na+/K + -ATPase activation, (4) modula-
tion of hormone/receptor interactions; (5) gene
transcription and; (6) mRNA translation [40–44].
OA can be obtained by either dietary consumption or
de novo lipogenesis. De novo lipogenesis of OA can
occur from both dietary carbohydrates (will be trans-
formed to triacylglycerol in case of positive energy bal-
ance) and fat. The enzyme responsible for MUFA OA
biosynthesis is SCD [45], which is considered as a key
enzyme in de novo lipogenesis, a process that is associ-
ated with obesity, synthesis of cholesterol and apoptosis.
In the present study, SCD was up-regulated in the group
of animals with high OA content. This was expected as
this gene function is linked to OA synthesis. Hulver et
al. [46] suggested that elevated expression of SCD1 in
human skeletal muscle contributes to abnormal lipid
metabolism and progression of obesity. However, in this
study, the IMF content between the L and H group was
not statistically different (p-value = 0.06), as the H group
had an average IMF content of 3.1% and the L group
had an IMF of 2.7%. In this study, the fatty acid synthase
(FAS) and acetyl-CoA carboxylase, responsible for fatty
acid metabolism, were not differentially expressed be-
tween the groups H an L for any FA studied, considering
that the diet was the same for all animals. This may indi-
cate: 1) the increased SCD1 in this study was associated
just with higher synthesis of OA and not with higher fat
deposition; 2) a difference in how bovine and human
skeletal muscles respond to OA content.
Schrauwen [47], Clapham et al. [48] reported that mice
which overexpressed UCP3 in skeletal muscle had lower
body weights and increased AMPK activity, elevated
metabolic rate, lower fasting plasma glucose and insulin
levels compared to wild type mice. In the first instance
UCP3, which was down-regulated in the group of animals
with high OA content was associated with regulation of
energy homeostasis, but according to Schrauwen et al.
[47] UCP3 played an important role in the protection of
mitochondria against lipid-induced oxidative damage by
ROS production. This protection was the result of better
fatty acid exportation by mitochondria and less produc-
tion of hydrogen peroxide (H2O2), which caused oxidative
damage to proteins and phospholipids. PLIN5, which was
down-regulated in the group of animals with high OA
content, in turn is a protein associated with lipid droplet
that maintains the balance between lipogenesis and lipoly-
sis and regulates fatty acid oxidation in oxidative tissues.
These proteins recruit mitochondria to the surface of lipid
droplets, which regulates their homeostasis by storing
fatty acids in the form of triglycerides and releasing fatty
acids for fatty acid oxidation by mitochondria [49]. CPT1,
which was up-regulated in the group of animals with high
OA content and CPT1B, which was down-regulated in the
group of animals with high OA content, are important for
the beta-oxidation of long chain fatty acids, which are in-
volved in the long chain fatty acids transport to the mito-
chondrial matrix and associated with type 2 diabetes and
insulin resistance. The inhibition of CPT1 decreases the
ability of muscles to oxidize fatty acids due to decreased
long chain fatty acids transport into muscle mitochondria
that could in turn be responsible for fat accumulation in
skeletal muscle [50]. In this study, animals with lower
values of OA content presented higher expression levels
(Figs. 1 and 4) of UCP3, PLIN5, CPT1 and CPT1B and
lower expression level of SCD, corroborating with these
previous studies [48–51] where the expression level of
these genes were associated with fatty acid metabolism,
energy homeostasis and animal health.
Herein, networks associated with reactive oxygen spe-
cies (ROS) generation such as oxidative phosphorylation
and mitochondrial dysfunction were detected, results
that corroborate previous studies that reported the role
of OA [52] and fatty acids [39] in the control of lipid
oxidation. Mitochondria, where β-oxidation occurs, are
the major source of ROS generation. Fatty acid mole-
cules are broken down to generate acetyl-CoA, which
enters the citric acid cycle, and NADH and FADH2 co-
enzymes are used in the electron transport chain [53].
Tizioto et al. [54] performed DEG gene analysis between
animals that showed high (inefficient) and low (efficient)
residual feed intake from the same population used in
this study, and indicated the metabolic processes that
underlie oxidative stress are a primarily network related
to lipid metabolism and energy required for mainten-
ance. These authors also observed the important role of
fatty acids in energy metabolism and mitochondrial ac-
tion on lipid oxidation process similar to that reported
in this study.
One of the major transcription factors identified in
our study was PPARGC1A, which was differentially
expressed between the H and L groups for CLA-c9t11
and down-regulated in H group. PPARGC1A is a tran-
scriptional coactivator that regulates genes involved in
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energy metabolism and provides a link between external
physiological stimuli and the regulation of mitochondrial
biogenesis. PPARGC1A regulates global oxidative metab-
olism by controlling both the induction of mitochondrial
metabolism and the removal of its ROS by-products,
which could elevate oxidative metabolism and minimize
the impact of ROS on cell physiology in muscle [55]. A
review by Puigserver and Spiegelman [56] reported that
the PPARGC1A transcriptional coactivator could be acti-
vated or not in response to environmental stimuli or by
cellular signals such as cAMP and cytokine pathways,
which control energy and nutrient homeostasis. Acti-
vated PPARGC1A stimulates mitochondrial oxidative
metabolism, fiber-type switching in skeletal muscle, and
the fasted response in liver [56]. These effects of
PPARGC1A are the result of gene expression regulation
by interacting specifically with other transcription fac-
tors such as nuclear hormone receptors, nuclear respira-
tory factors, and muscle-specific transcription factors.
Another important TF associated with lipid metabolism,
FOXO1, which regulates the transcriptional cascades of
glucose metabolism was differentially expressed in the
current study for CLA-c9t11. FOXO1, which was down-
regulated in the group of animals with high CLA-c9t11
content, is highly expressed in tissues such as pancreas,
liver, skeletal muscle and adipose tissue in response to
insulin and is associated with metabolic disorders as dys-
lipidemia (Fig. 5). Dyslipidemia is a metabolic disorder
that contributes to the development of atherosclerosis due
to the elevation of plasma cholesterol, triglycerides (TGs)
or low high-density lipoprotein level [57]. These results
are in agreement with a previous study, which indicated
that the level of CLA in human diet can influence athero-
sclerosis in animal models [58].
The functional annotation analysis by IPA® for tran-
scripts associated with FAs with many DEG (i.e. OA and
CLA-c9t11) included important TFs, such as PPARGC1A,
SREBF1, TP53, FOXO1 and MYC as upstream regulators.
In addition, biological processes, which can cause damage
to human and animals health, were identified as enriched.
Several disorders, diseases, molecular and cellular func-
tions were also identified as associated with OA or CLA-
c9t11 FA content in skeletal muscle by transcriptome pro-
filing (Additional files 13 and 18).
Two important genes associated with lipid metabolism,
gene expression and cancer were identified as DEGs be-
tween animals with high and low CLA-c9t11, specifically,
epidermal growth factor receptor (EGFR, Fig. 5) and RNPS
(Fig. 6). EGFR is a tyrosine protein kinase, which has been
implicated in several biological processes such as cell
growth, survival, and migration. The overexpression of
EGFR was associated with breast, lung and colon cancers
[59, 60]. In this study, the EGFR was down-regulated in
animals with high CLA-c9t11 content, result that agree
with the association between CLA-c9t11 content and can-
cer prevention. RNPS, which was up-regulated in the
group of animals with high CLA-c9t11 content, can affect
several basic functions such as protein synthesis, gene ex-
pression, and chromosome stability. It is responsible for
pseudouridylation of ribosomal and spliceosomal small
nuclear RNAs, ribosomal RNAs processing, and RNA
telomerase stabilization [61]. MacDonald [62] and Park et
al. [63] reported that association of CLA-c9t11 transcrip-
tome level can regulate cell proliferation and differentiation.
Conclusions
The effective involvement of OA and CLA-c9t11 in bio-
logical processes like transcriptional regulation is still
unclear. However, this transcriptome profiling study,
which used Longissimus dorsi muscle from cattle with
extreme values of OA and CLA-c9t11 content, demon-
strated that both OA and CLA-c9t11 content had large
effects on the expression level of genes related to im-
portant biological processes associated with oxidative
phosphorylation, cell growth, survival, and migration. It
is tempting to speculate that these fatty acids have direct
and maybe indirect physiological effects on skeletal
muscle, while other fatty acids do not. Additional nutri-
genomic and metabolomic studies are necessary to eluci-
date the metabolic mechanisms by which these fatty
acids influence cell growth, survival, and migration,
which are interestingly also associated with several hu-
man diseases directly related to human dietary intake of
fatty acids.
Methods
Animals, samples and phenotypes
Three hundred and ninety Nellore steers from the
Brazilian Agricultural Research Corporation (EMBRAPA/
Brazil) experimental breeding herd between 2009 and
2011 were included in this study; see Cesar et al. [21] for
additional details. These steers were sired by 34 unrelated
sires that represented most of the main genealogies used
in Brazil according to the National Summary of Nellore
produced by the Brazilian Association of Zebu Breeders
(ABCZ) and National Research Center for Beef Cattle.
Animals were raised in feedlots under identical nutrition
and handling conditions until slaughter at an average age
of 25 months. Samples from LD muscle located between
the 12th and 13th ribs were collected in two time-points:
at slaughter for RNA sequencing analysis to guarantee the
RNA integrity, and 24 h after slaughter for the fatty acid
content measurement according to research guidelines for
cookery, sensory evaluation and instrumental tenderness
measurements of fresh meat [64].
Approximately 100 g samples of LD muscle were ly-
ophilized and ground to a fine powder. Five grams of
this ground, lyophilized tissue was used to measure the
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OA, PA, SA, CLA-c9t11, EPA, DHA and LA content,
which were chosen based on their importance in many
biological processes and human health [35–40]. The
fatty acid content measurement was conducted as de-
scribed by Hara and Radin [65], except the hexane to
propanol ratio was increased to 3:2. Approximately 4 g
of LD muscle were lyophilized, ground in liquid nitro-
gen, mixed with 28 mL of hexane/propanol (3:2 vol/vol)
and homogenized for 1 min. Samples were vacuum fil-
tered and 12 mL sodium sulfate (67 mg mL− 1) solution
was added and agitated for 30 s. The supernatant was
transferred to a tube with 2 g of sodium sulfate and
insufflated with nitrogen gas (N2), after which the tube
was sealed and incubated at room temperature for
30 min. Subsequently, the liquid was transferred to
10 mL test tube, insufflated with N2, sealed and kept at
-20 °C until dry with N2 for methylation. The extracted
lipids were hydrolyzed and methylated as described by
Christie [66], except that hexane and methyl acetate
were used instead of hexane:diethyl ether:formic acid
(90:10:1). Around 40 mg of lipids were transferred to a
tube containing 2 mL of hexane. Subsequently, 40 μL of
methyl acetate were added, the sample agitated, and
40 μL of methylation solution (1.75 mL of methanol/
0.4 mL of 5.4 mol/L of sodium metoxyde) were added.
This mixture was agitated for 2 min and incubated for
10 min at room temperature. Then 60 μL of finishing
solution (1 g of oxalic acid/30 mL of diethyl ether) was
added and the mixture was agitated for 30 s, after which
200 mg of calcium chloride was added. The sample was
then mixed and incubated at room temperature for 1 h.
Samples were centrifuged at 3200 rpm, for 5 min at 5 °C.
The supernatant was collected for determination of fatty
acid. Fatty acid methyl esters were quantified with a gas
chromatograph (ThermoFinnigan, Termo Electron Corp.,
MA, USA) equipped with a flame ionization detector and a
100 m Supelco SP-2560 (Supelco Inc., PA, USA) fused silica
capillary column (100 m, 0.25 mm and 0.2 μ m film thick-
ness). The column oven temperature was held at 70 °C for
4 min, then increased to 170 °C at a rate of 13 °C min − 1,
and subsequently increased to 250 °C at a rate of 35 °C min
− 1, and held at 250 °C for 5 min. The gas fluxes were
1.8 mL min− 1 for carrier gas (He), 45 mL min − 1 for
make-up gas (N2), 40 mL min − 1 for hydrogen, and
450 mL min − 1 for synthetic flame gas. One μL sample was
analyzed. Injector and detector temperatures were 250 and
300 °C, respectively. The fatty acids were identified by com-
parison of retention time of methyl esters of the samples
with standards of fatty acids butter reference BCR-CRM
164, Anhydrous Milk Fat-Producer (BCR Institute for Mate-
rials and Reference Measurements) and also with commer-
cial standard for 37 fatty acids Supelco TM Component
FAME Mix (cat 18919, Supelco, Bellefonte, PA). The fatty
acid content was quantified by normalizing the area under
the curve of methyl esters using Chromquest 4.1 software
(Thermo Electron, Italy). The fatty acid content was
expressed as a weight percentage (mg/mg). These analyses
were performed at the Animal Nutrition and Growth
Laboratory at ESALQ, Piracicaba, São Paulo, Brazil.
From a total of 390 animals, we selected 30 animals
with either the highest (H) or lowest (L) FA content for
each one of the FA chosen (OA, PA, SA, CLA-c9t11,
EPA, DHA and LA) to form the groups that were tested
for differential expression analysis. Data from some ani-
mals were used in more than one analysis, which re-
sulted in a total of 164 animals that were used on this
study. The extreme values of FAs were identified based
in their adjusted phenotype values, which was estimated
via regression as recommended by Naylor et al. [67] and
selected for differential gene expression analysis. SAS
PROC MIXED (SAS version 9.1) was used to adjust the
phenotypic values and run the regression model, in
which the contemporary group (animals with the same
origin, birth year and slaughter date) and hot carcass
weight were fitted as fixed and covariate, respectively.
To verify the difference of FA content between the high
and low groups, IMF (%) and BFT (mm) a Student’s t-test
was performed using R package. Because of some samples
were used in more than one FA extreme group, the statis-
tical test of means was performed between the high (H)
and low (L) groups according to FA by Student’s t-test
performed in R package. Pairwise correlation analysis was
also performed for all FAs. The IMF and BFT measure-
ment were obtained as described by Cesar et al. [21] and
Tizioto et al. [68].
RNA extraction, quality analysis, library preparation and
sequencing
Total RNA was extracted from 100 mg of frozen LD
muscle that was collected at slaughter using the TRIzol
reagent (Life Technologies, Carlsbad, CA). RNA integrity
was verified by Bioanalyzer 2100 (Agilent, Santa Clara,
CA, USA). Only samples with RIN score > 8 were used.
A total of 2 μg of total RNA from each sample was used
for library preparation according to the protocol de-
scribed in the TruSeq RNA Sample Preparation kit v2
guide (Illumina, San Diego, CA). The average insert size
of the libraries was estimated using the Agilent Bioanaly-
zer 2100 (Agilent, Santa Clara, CA, USA) and quantified
using quantitative PCR with the KAPA Library Quantifi-
cation kit (KAPA Biosystems, Foster City, CA, USA).
Quantified, samples were diluted and pooled (three
pools of six samples each). Three lanes of a sequencing
flowcell, using the TruSeq PE Cluster kit v3-cBot-HS kit
(Illumina, San Diego, CA, USA), were clustered and
sequenced using HiSeq2500 ultra-high-throughput se-
quencing system (Illumina, San Diego, CA, USA) with
the TruSeq SBS Kit v3-HS (200 cycles), according to
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manufacturer instructions. The sequencing analyses
were performed at the Genomics Center at ESALQ,
Piracicaba, São Paulo, Brazil.
Quality control and read alignment
Sequencing adaptors and low-complexity reads were re-
moved in an initial data filtering step. Quality control
and reads statistics were estimated with FASTQC ver-
sion 0.10.1 software [http://www.bioinformatics.bbsrc.a-
c.uk/projects/fastqc/]. Tophat v. 2.0.11 software [69]
with Bowtie2 (version 2.2.3) [70] was used to map reads
to the UMD3.1 Bos taurus reference assembly available
at Ensembl [http://www.ensembl.org/Bos_taurus/Info/
Index/]. The abundance (read counts) of mRNAs for all
annotated genes was calculated using HTSeq version
0.6.1 software [http://www-huber.embl.de/users/anders/
HTSeq/] [71]. Only sequence reads that uniquely mapped
to known chromosomes (excluding reads mapped to un-
assigned contigs) were used in further analyses.
Identification of differential expressed genes and
pathway analysis
Differentially expressed genes were identified using the
DESeq2 statistical package available at Bioconductor
open source software for bioinformatics [72], using
multi-factor design. Prior to statistical analysis, read
count data was filtered as follows: i) transcripts with
zero counts were removed (unexpressed); ii) genes with
less than 1 read per sample on average were removed
(very lowly expressed); iii) genes that were not present in
at least three samples were removed (rarely expressed).
Transcript expression level was fit as a negative binomial
distribution. Age (covariate) and contemporary group
(animals with the same origin, birth year and slaughter
date; class effect) were fit as factors in the multi-factor
model. Exploratory diagnostic plots were generated to
check the dispersion estimates. The cut-off approach
performed to identify the DEGs was Benjamini-
Hochberg [15] methodology was used to control false
discovery rate (FDR) at 10%.
Enrichment analysis of gene ontology terms was com-
pleted with the Database for Annotation, Visualization
and Integrated Discovery (DAVID) v6.7 tool [73] using
the list of genes that presented FDR < 10%. The func-
tional analysis of statistically significant gene expression
changes (FDR 10%) between the groups was performed
with QIAGEN’s Ingenuity® Pathways Analysis (IPA®,
QIAGEN Redwood City, www.qiagen.com/ingenuity),
which uses the Fisher’s exact test to calculate a p-value
for each biological function assigned to the experimental
data. These analyses were performed just for OA and
CLA-c9t11 because they presented higher impact on
gene expression level.
Quantitative real-time PCR analysis
Total RNAs of three samples of each group (H and L)
and nine DE genes were randomly selected for quantita-
tive PCR analysis. The High Capacity cDNA Reverse
Transcription Kit (Life Technologies, Grand Island, NY)
was performed in reverse transcription (RT) as manufac-
turer’s procedure. The RT reaction contained 150 ng of
total RNA, 1 μL of 10× RT buffer, 0.5 μl of 25× dNTP
mixture, 1 μL of 10× random reverse primers, 1 μL of
10× gene-specific reverse primers (1 μM) and 0.5 μLof
MultiScribe RT (50 U/μl). The reactions of 10 μL were
incubated in thermocycler for 10 min at 25 °C, 2 h at
37 °C and then held at 4 °C. All samples were treated
with Ambion TURBO DNA-free® DNase (Life Technolo-
gies, Grand Island, NY) to remove contaminating DNA
from RNA preparations. Quantitative real-time PCR was
performed on an Applied Biosystems QuantStudio™ 12 K
Flex System (Thermo Fisher Scientific, Waltham, MA)
using the TaqMan OpenArray gene expression plates. The
TaqMan assays of nine DE genes selected (NDUFV1,
NDUFS6, NDUFB7, COX7A1, CYP4B1, JAM2, PLIN5,
COA5 and NDUFS8) for this study was designed and per-
formed by manufacturer (http://www.thermofisher.com/
order/genome-database). The PCR reaction (1.2 μLof
sample plus 3.8 μL of PCR mix) was prepared for all sam-
ples and placed into 384-well sample plate. The PCR reac-
tions were dispensed using the Accufill System onto the
corresponding OpenArray plate. The PCR condition was
performed as manufacturer’s procedure. The comparative
Ct method for quantification was performed to quantify
the relative expression of specific genes by QuantStudio
12 K Flex Software (Thermo Fisher Scientific, Waltham,
MA) according to Pfaffl [74]. Eukaryotic Translation
Elongation Factor 1 Alpha 2 (EEF1A2 - Bt03229236_mH)
and Beta-2-Microglobulin (B2M - Bt03251628_m1) were
selected as reference genes to normalize gene expression.
Analysis of covariance (ANCOVA) [75] using the same
fixed effect and covariate used in RNA-Seq analysis was
performed to test the significance (p < 0.10) of FA content
(group effect) on gene expression level of the DE genes se-
lected randomly for this study.
Data availability
The dataset supporting the conclusions of this article is
available in the in the European Nucleotide Archive (ENA)
repository (EMBL-EBI), under accession PRJEB13188
[http://www.ebi.ac.uk/ena/data/view/PRJEB13188].
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